Fig. 3From: Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosisDevelopment of genetically, hematological and biochemical values during the follow up of the patient. The diagnosis of AML is set to time point 0, and the negative values indicate days before the AML diagnosis, and the positive value days after the AML diagnosisBack to article page